Clinical Trial Update: Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection [Phase 2]

View source ↗

Summary

Phase 2 trial investigating thalidomide for oral/esophageal aphthous ulcers and HIV viremia in HIV-infected patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphthous Stomatitis
• HIV Infection
• Stomatitis

Drugs mentioned

• Thalidomide (thalidomide)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections, Stomatitis, Aphthous | Phase 2 | Status: COMPLETED